| |
| |
|
| Insider
Information: |
Roach James M. |
| Relationship: |
Senior VP, Development... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
155,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,154,395 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
155,381 |
|
|
| Total
Value |
$8,154,395 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Development... |
2016-11-22 |
155,381 |
2009-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-11-21 |
4 |
AS |
$15.01 |
$2,897 |
D/D |
(193) |
70,001 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-08-21 |
4 |
AS |
$13.78 |
$2,660 |
D/D |
(193) |
78,426 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-11-20 |
4 |
AS |
$10.96 |
$2,115 |
D/D |
(193) |
77,854 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-05-20 |
4 |
AS |
$18.55 |
$3,599 |
D/D |
(194) |
70,772 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-08-19 |
4 |
AS |
$15.67 |
$3,040 |
D/D |
(194) |
70,387 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-05-23 |
4 |
AS |
$13.03 |
$2,541 |
D/D |
(195) |
87,558 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-05-21 |
4 |
AS |
$12.83 |
$2,528 |
D/D |
(197) |
87,753 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-08-20 |
4 |
AS |
$14.47 |
$2,851 |
D/D |
(197) |
87,143 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-11-19 |
4 |
AS |
$17.17 |
$3,382 |
D/D |
(197) |
86,537 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-02-19 |
4 |
AS |
$17.86 |
$3,518 |
D/D |
(197) |
106,209 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-05-22 |
4 |
AS |
$11.74 |
$2,336 |
D/D |
(199) |
103,871 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-08-22 |
4 |
AS |
$11.32 |
$2,253 |
D/D |
(199) |
103,013 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-11-24 |
4 |
AS |
$11.53 |
$2,294 |
D/D |
(199) |
102,155 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-02-23 |
4 |
AS |
$12.93 |
$2,573 |
D/D |
(199) |
120,347 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-05-15 |
4 |
AS |
$13.33 |
$2,893 |
D/D |
(217) |
87,950 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-11-15 |
4 |
AS |
$16.88 |
$3,663 |
D/D |
(217) |
86,734 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-02-18 |
4 |
AS |
$17.96 |
$3,897 |
D/D |
(217) |
86,128 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-05-15 |
4 |
AS |
$11.09 |
$2,407 |
D/D |
(217) |
104,320 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-08-15 |
4 |
AS |
$11.75 |
$2,550 |
D/D |
(217) |
103,462 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-11-17 |
4 |
AS |
$10.64 |
$2,309 |
D/D |
(217) |
102,604 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-08-15 |
4 |
AS |
$15.43 |
$3,364 |
D/D |
(218) |
87,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-02-20 |
4 |
AS |
$13.40 |
$3,337 |
D/D |
(249) |
120,546 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-08-22 |
4 |
AS |
$12.10 |
$3,013 |
D/D |
(249) |
156,472 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-05-20 |
4 |
AS |
$12.08 |
$3,020 |
D/D |
(250) |
104,070 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-08-20 |
4 |
AS |
$11.54 |
$2,885 |
D/D |
(250) |
103,212 |
0 |
- |
|
97 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
